New Delhi. API Holdings, the parent company of e-commerce pharmacy platform PharmEasy, has submitted documents to capital markets regulator SEBI to raise Rs 6.250 crore through the initial sale of shares. According to Draft Red Herring Prospects (DRHP), the amount will be raised by issuing new equity shares.
The company can conduct a private placement of shares worth Rs 1,250 million. If there is a pre-IPO placement, the size of the problem will be reduced. The company has used the proceeds from the IPO to pay off outstanding debt of Rs 1929 crore, to fund an organic growth plan of Rs 1259 crore, for inorganic growth and general corporate spending through acquisitions of Rs 1500 crore and other strategic initiatives. do.
API Holdings is a leading digital healthcare platform. Its investors include Prosus Ventures (formerly Naspers Ventures), TPG Growth, Temasek, CDPQ, LGT LightRock, Eight Rhodes and Think Investments.
Citigroup Global Markets India, JM Financial Ltd., Kotak Mahindra Capital, Morgan Stanley India and BofA Securities India have been appointed as lead bookkeepers for the issue.
In June this year, PharmEasy, which is in charge of drug deliveries, announced that it would acquire a majority stake in the diagnostic chain Thyrocare for 4,546 million rupees.
Read also: Nykaa shares enriched investors, the company’s market capitalization also crossed Rs 1 lakh crore
Read also: For better children’s education, you will have to spend a lot, follow these ways to add enough money
Read also: SpiceJet gave a gift after Diwali, now everyone will prefer to travel by plane instead of train
Read also: We couldn’t reach the goal even after 5 years of demonetization.